Skip to content

Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions

Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02545790
Acronym
LVOTO
Enrollment
31
Registered
2015-09-10
Start date
2015-08-31
Completion date
2020-12-31
Last updated
2021-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coarctation of Aorta, Aortic Stenosis, Cardiac Hypertrophy

Keywords

coarctation of aorta, aortic stenosis, biomarkers, cardiac hypertrophy

Brief summary

This study is designed to learn more about children who have blockage of the left side of their heart. The goal is to determine how much the heart muscle has thickened before surgery and how it changes in the months after surgery. Investigators are also looking for blood tests that may help them predict which patients will have the most thickening pre-operatively and the best return towards normal after surgery. The findings of this study will help the investigators develop new tests to monitor affected patients and develop new therapies to help minimize heart thickening.

Interventions

PROCEDUREEchocardiogram

2 and 3-dimensional echocardiographic images will be obtained to estimate LV mass, ejection fraction (Simpson's biplane), fractional shortening (M mode Doppler), and pulse-wave estimated pressure gradient across the outflow obstruction.

BIOLOGICALSerology

protein analysis targeting several potential protein biomarkers for cardiac remodeling and hypertrophy as well as targeting known miRNAs.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Congenital heart disease patients with the following diagnoses undergoing surgical repair: Coarctation of the aorta (CoA), aortic stenosis (AS), subaortic membrane (sub-AS), supravalvar aortic stenosis (supra-AS). * All patients will have age from birth through 18 years of age. * While we will generally not enroll patients with other co-morbid heart disease that would alter the cardiac physiology (see

Exclusion criteria

), patients with patent foramen ovale, atrial septal defect, and patent ductus arteriosus specifically will be allowed.

Design outcomes

Primary

MeasureTime frameDescription
Left ventricular mass1 year after surgeryLeft ventricular mass will be measured by 2D echocardiography at 1 year after surgical correction.
Change in left ventricular massWithin 1 week prior to surgery, 24-72 hrs after surgery, 1 year after surgeryLeft ventricular mass will be measured by 2D echocardiography prior to surgery, immediately after surgery, and will be compared to that measured at 1 year after surgical correction.

Secondary

MeasureTime frameDescription
Relative wall thickness1 year after surgeryA more detailed measure of relative wall thickness (RWT) will be assessed by echocardiography at 1 year after surgical correction.
Left ventricular mass1 year after surgeryLeft ventricular mass will be measured by 3D echocardiography at 1 year after surgical correction.
Change in relative wall thicknessWithin 1 week prior to surgery and 1 year after surgeryRelative wall thickness will be measured by 2D echocardiography prior to surgery and at 1 year after surgical correction.
Change in left ventricular mass24-72 hours and 1 year after surgeryChange in left ventricular mass will be measured by 3D echocardiography 24-72 hours and 1 year after surgical correction.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026